Perceptive Advisors - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$6,899,000
-90.7%
284,853
-91.0%
0.14%
-75.8%
Q4 2021$73,944,000
+103.2%
3,168,104
+124.6%
0.57%
+23.9%
Q1 2021$36,386,000
+7449.0%
1,410,305
+12429.4%
0.46%
+4500.0%
Q4 2019$482,000
+20.5%
11,256
-24.4%
0.01%
-9.1%
Q1 2019$400,000
-93.5%
14,897
-94.6%
0.01%
-93.6%
Q1 2018$6,179,000
+88171.4%
275,000
+175.0%
0.17%
Q4 2016$7,000
-99.7%
100,000
+53.3%
0.00%
-100.0%
Q3 2016$2,075,000
-79.1%
65,240
-85.7%
0.13%
-84.6%
Q1 2016$9,933,000
-49.2%
455,240
-24.2%
0.87%
-42.7%
Q1 2015$19,562,000
-43.6%
600,240
-45.1%
1.52%
-47.8%
Q4 2014$34,712,000
+27.7%
1,093,281
-0.4%
2.91%
-0.3%
Q3 2014$27,184,000
+84.3%
1,097,914
+68.1%
2.92%
+101.7%
Q2 2014$14,751,000
-9.0%
653,000
-2.0%
1.45%
-15.0%
Q1 2014$16,204,000
-51.7%
666,000
-45.5%
1.70%
+23.3%
Q3 2013$33,548,000
+154.4%
1,221,230
+68.1%
1.38%
+3.8%
Q2 2013$13,188,000726,6291.33%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders